Diabetic nephropathy: Study results on proteomic analysis do not show benefit

(Institute for Quality and Efficiency in Health Care) First study on a treatment strategy using a proteomic analysis does not clarify which therapeutic consequence of the test could offer a benefit for people with diabetes and high blood pressure.